Skip to main content
Top
Published in: Clinical Rheumatology 8/2017

01-08-2017 | Original Article

Lung involvement in “stable” undifferentiated connective tissue diseases: a rheumatology perspective

Authors: Antonella Riccardi, Rosaria Irace, Ilaria Di Stefano, Michele Iudici, Serena Fasano, Marialuisa Bocchino, Annalisa Capaccio, Alessandro Sanduzzi, Gabriele Valentini

Published in: Clinical Rheumatology | Issue 8/2017

Login to get access

Abstract

Previous studies of the occurrence of interstitial lung disease (ILD) in undifferentiated connective tissue diseases (UCTD) were conducted in patients admitted to Respiratory Medicine Units. The aim of the present prospective study was to investigate lung involvement in UCTD patients admitted to a Rheumatology Unit. Eighty-one consecutive UCTD patients were enrolled in the study. Each patient underwent history and physical examination, routine laboratory investigations, antinuclear antibody (ANA) profiling, B-mode echocardiography, and lung function study according to previously reported methods. Lung high resolution computed tomography (HRCT) was performed in patients who provided informed consent. Six patients (7.4%) had a history of grade II dyspnea. Three of them had a DLCO ranging from 42 to 55% of the predicted value; and a HRCT-documented ILD with a non-specific interstitial pneumonia (NSIP) pattern. Symptoms in the other three patients were due to cardiac disease. None of the 75 asymptomatic patients, had relevant findings at physical examination, 26/75 had a DLCO <80% (<70% in 10 cases). Of these, 3 of the 30 patients who underwent lung HRCT were affected by NSIP-ILD. Six of the 81 enrolled were affected by ILD, which was symptomatic in three patients. A higher percentage of patients had a reduced DLCO. The latter finding may reflect a preradiographic ILD or a preechocardiographic pulmonary vascular disease.
Literature
1.
go back to reference Fischer A, du Bois R (2012) Interstitial lung disease in connective tissue in connective tissue disorders. Lancet 280:689–698CrossRef Fischer A, du Bois R (2012) Interstitial lung disease in connective tissue in connective tissue disorders. Lancet 280:689–698CrossRef
2.
go back to reference Wells AU, Denton CP (2014) Interstitial lung disease in connective tissue disease: mechanisms and management. Nat Rev Rheumatol 10:728–739CrossRefPubMed Wells AU, Denton CP (2014) Interstitial lung disease in connective tissue disease: mechanisms and management. Nat Rev Rheumatol 10:728–739CrossRefPubMed
3.
go back to reference Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B et al (2007) Idiopathic nonspecific interstitial pneumonia lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176:691–697CrossRefPubMedPubMedCentral Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B et al (2007) Idiopathic nonspecific interstitial pneumonia lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176:691–697CrossRefPubMedPubMedCentral
4.
go back to reference Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA et al (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149CrossRefPubMedPubMedCentral Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA et al (2010) Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 188:143–149CrossRefPubMedPubMedCentral
5.
go back to reference Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease associated interstitial lung disease: a call for clarification. Chest 138:251–256CrossRefPubMedPubMedCentral Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM (2010) Connective tissue disease associated interstitial lung disease: a call for clarification. Chest 138:251–256CrossRefPubMedPubMedCentral
7.
go back to reference Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD et al (2015) An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976–987CrossRefPubMed Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD et al (2015) An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976–987CrossRefPubMed
8.
go back to reference Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): review of the literature and proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620PubMed Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): review of the literature and proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620PubMed
9.
go back to reference Doria A, Mosca M, Gambari PF, Bombardieri S (2005) Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 32:213–215PubMed Doria A, Mosca M, Gambari PF, Bombardieri S (2005) Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 32:213–215PubMed
10.
go back to reference Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2005) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48-49:50–52CrossRef Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S (2005) The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 48-49:50–52CrossRef
11.
go back to reference Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spanò A (2014) Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis Care Res (Hoboken) 66(10):1520–1527CrossRef Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spanò A (2014) Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis Care Res (Hoboken) 66(10):1520–1527CrossRef
12.
go back to reference Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165CrossRefPubMed Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165CrossRefPubMed
13.
go back to reference Maione S, Cuomo G, Giunta A et al (2005) Echocardiographic alterations in systemic sclerosis. A longitudinal study. Semin Arthritis Rheum 34:721–727CrossRefPubMed Maione S, Cuomo G, Giunta A et al (2005) Echocardiographic alterations in systemic sclerosis. A longitudinal study. Semin Arthritis Rheum 34:721–727CrossRefPubMed
14.
go back to reference American Thoracic Society (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152:2185–2198CrossRef American Thoracic Society (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152:2185–2198CrossRef
15.
go back to reference American Thoracic Society (1995) Standardization of spirometry—1995 update. Am J Respir Crit Care Med 152:1107–1136CrossRef American Thoracic Society (1995) Standardization of spirometry—1995 update. Am J Respir Crit Care Med 152:1107–1136CrossRef
16.
go back to reference Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 28:759–767CrossRefPubMed Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA (1985) Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 28:759–767CrossRefPubMed
17.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968CrossRefPubMed
18.
go back to reference Staitieh BS, Ioachimescu O (2017) Interpretation of pulmonary function tests: beyond the basics. J Investig med 65:301–310CrossRefPubMed Staitieh BS, Ioachimescu O (2017) Interpretation of pulmonary function tests: beyond the basics. J Investig med 65:301–310CrossRefPubMed
19.
go back to reference Fischer A, Brown KK (2015) Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res (Hoboken) 67:4–11CrossRef Fischer A, Brown KK (2015) Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res (Hoboken) 67:4–11CrossRef
20.
go back to reference Suda T, Kono M, Nakamura Y, Enomoto N, Kaida Y, Fujisawa T et al (2010) Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 104:1527–1534CrossRefPubMed Suda T, Kono M, Nakamura Y, Enomoto N, Kaida Y, Fujisawa T et al (2010) Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 104:1527–1534CrossRefPubMed
21.
go back to reference Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr (1992) Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 35:765–770CrossRefPubMed Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr (1992) Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 35:765–770CrossRefPubMed
22.
go back to reference Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S et al (2015) Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders. Semin Arthritis Rheum 44:437–444CrossRefPubMed Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S et al (2015) Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders. Semin Arthritis Rheum 44:437–444CrossRefPubMed
23.
go back to reference Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P et al (2016) Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis 75:374–381CrossRefPubMed Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P et al (2016) Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis 75:374–381CrossRefPubMed
24.
go back to reference Khanna D, Seibold JR, Wells A, Distler O, Allanore Y, Denton C et al (2010) Systemic sclerosis-associated interstitial lung disease: lessons from clinical trials, outcome measures, and future study design. Curr Rheumatol Rev 6:138–144CrossRefPubMedPubMedCentral Khanna D, Seibold JR, Wells A, Distler O, Allanore Y, Denton C et al (2010) Systemic sclerosis-associated interstitial lung disease: lessons from clinical trials, outcome measures, and future study design. Curr Rheumatol Rev 6:138–144CrossRefPubMedPubMedCentral
25.
go back to reference Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C et al (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15:61–70CrossRefPubMed Ferri C, Manfredi A, Sebastiani M, Colaci M, Giuggioli D, Vacchi C et al (2016) Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 15:61–70CrossRefPubMed
Metadata
Title
Lung involvement in “stable” undifferentiated connective tissue diseases: a rheumatology perspective
Authors
Antonella Riccardi
Rosaria Irace
Ilaria Di Stefano
Michele Iudici
Serena Fasano
Marialuisa Bocchino
Annalisa Capaccio
Alessandro Sanduzzi
Gabriele Valentini
Publication date
01-08-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3704-8

Other articles of this Issue 8/2017

Clinical Rheumatology 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.